These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4098488)

  • 1. [Serum protein -(Xh)-changes in pregnancy and use of ovulation inhibitons in women and men].
    Geserick G; Müller G
    Zentralbl Gynakol; 1970 Sep; 92(37):1195-200. PubMed ID: 4098488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protein metabolism in women using Femigen Polfa as peroral contraceptives].
    Firek A; Pisarek-Miedzińska D; Wójcicka J; Korc R
    Ginekol Pol; 1973 Nov; 44(11):1303-8. PubMed ID: 4129073
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum vitamin B 12 binding capacity and oral contraceptive hormones.
    Bianchine JR; Bonnlander B; Macaraeg PV; Hersey R; Bianchine JW; McIntyre PA
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1425-8. PubMed ID: 4186909
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with Ovosiston for inhibition of ovulation].
    Kühne D
    Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of serum copper and iron under the influence of the ovulation inhibitor Ovosiston].
    Methfessel HD; Mlytz H; Methfessel G; Löffler F
    Z Gesamte Inn Med; 1969 Oct; 24(19):659-61. PubMed ID: 4188438
    [No Abstract]   [Full Text] [Related]  

  • 6. Cooperative studies of sequens, a sequential oral contraceptive agent, in Japan.
    Sawasaki C; Ashitaka Y
    J Jpn Obstet Gynecol Soc; 1968 Apr; 15(2):96-107. PubMed ID: 4175084
    [No Abstract]   [Full Text] [Related]  

  • 7. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ovulation inhibitors and the sexual behavior of women].
    Aresin L
    Z Gesamte Hyg; 1970 Apr; 16(4):291-2. PubMed ID: 4108398
    [No Abstract]   [Full Text] [Related]  

  • 9. [Investigations on the influence of ovulation inhibitors on the development and prognosis of chronic hepatopathies].
    Sensing H
    Dtsch Gesundheitsw; 1974 Mar; 29(9):405-7. PubMed ID: 4142435
    [No Abstract]   [Full Text] [Related]  

  • 10. [The serum levels of nonesterified fatty acids and free amino acids under the effect of the oral contraceptive, Ovosiston].
    Methfessel HD; Mlytz H; Liedtke MP; Löffler F; Methfessel G
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):880-2. PubMed ID: 4098228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ovulation inhibitors and oral contraceptive agents. 3].
    Albrecht JH
    Pharm Prax; 1967; 5():115-23. PubMed ID: 4179423
    [No Abstract]   [Full Text] [Related]  

  • 12. [The spermatozoa penetration in vivo under ovosiston. (Results of 54 Sims-Huhner tests)].
    Kempf HJ; Müller R; Eckert L
    Zentralbl Gynakol; 1968 Nov; 90(48):1630-9. PubMed ID: 4179432
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone alterations by a sequential-type oral contraceptive.
    Spellacy WN; Buhi WC; Bendel RP
    Obstet Gynecol; 1969 Apr; 33(4):506-10. PubMed ID: 4180423
    [No Abstract]   [Full Text] [Related]  

  • 14. [Towards a more physiological hormonal contraception].
    Stĕrba R
    Zentralbl Gynakol; 1970 Mar; 92(10):303-12. PubMed ID: 4096927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclicly dependent variations in efficiency of the voice and its influencing by ovulation inhibitors].
    Wendler J
    Folia Phoniatr (Basel); 1972; 24(4):259-77. PubMed ID: 4117286
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of the oral contraceptive Ovosiston on the composition of human milk.
    Ramadan MA; Salah MM; Eid SZ; Sammour MB
    J Reprod Med; 1972 Aug; 9(2):81-3. PubMed ID: 4115112
    [No Abstract]   [Full Text] [Related]  

  • 17. Endometrial morphology after sequential medication with mestranol and chlormadinone.
    Ober WB; Decker A; Clyman MJ; Roland M
    Obstet Gynecol; 1966 Aug; 28(2):247-53. PubMed ID: 4161461
    [No Abstract]   [Full Text] [Related]  

  • 18. Electroencephalographic changes during long term treatment with oral contraceptives.
    Matsumoto S; Sato I; Ito T; Matsuoka A
    Int J Fertil; 1966; 11(2):195-204. PubMed ID: 4163250
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetic studies on women using oral contraceptives and their progeny.
    McQuarrie HG; Scott CD; Ellsworth HS; Harris JW; Stone RA
    Am J Obstet Gynecol; 1970 Oct; 108(4):659-65. PubMed ID: 4096928
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipid metabolism in women ingesting gestagens as contraceptives].
    Pisarek-Miedzińska D; Roszkowski I; Firek A
    Ginekol Pol; 1972; 43(12):1407-19. PubMed ID: 4119343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.